| HOME >> BIOLOGY >> TECHNOLOGY |
respectively 19 29
Prepaid expenses and other current assets 1,064 2,300
Total current assets 18,575 20,040
Property, plant and equipment, net 1,938 2,260
Long-term investments, at fair value 2,902 -
Other assets 638 716
Total assets $24,053 $23,016
Liabilities and Stockholders' Deficit
Current liabilities:
Accounts payable $2,975 $2,401
Accrued liabilities 3,595 4,645
Current portion of convertible senior notes,
net of discounts 2,471 -
Total current liabilities 9,041 7,046
Long-term debt owed to related party 10,000 7,083
Convertible senior notes, net of discount 16,196 18,428
Other liabilities 278 360
Total liabilities 35,515 32,917
Stockholders' deficit:
Common stock 6 39
Additional paid-in capital 227,895 207,991
Accumulated deficit (239,142) (217,860)
Accumulated other comprehensive loss (221) (71)
Total stockholders' deficit (11,462) (9,901)
Total liabilities and stockholders' deficit $24,053 $23,016
(1) The condensed consolidated balance sheet at December 31, 2006 has been
derived from the audited consolidated financial statements at that
date included
'/>"/>
| SOURCE Vermillion, Inc. Copyright©2008 PR Newswire. All rights reserved |